CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Allergan USA, Inc. v. Prollenium US Inc.

1:20-cv-00104

Overview

Case Number 1:20-cv-00104
Filing Date 2020-01-23
Status Terminated
Termination Date 2021-02-22
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:1 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Prollenium Medical Technologies Inc. NPE (Patent Assertion Entity)

Represented By

4 Attorneys Listed

Warren J. Thomas

Email: wthomas@mcciplaw.com

Robert J. Leonard

Email: rleonard@mcciplaw.com

John W. Harbin

Email: jharbin@mcciplaw.com

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Prollenium US Inc. Operating Company

Represented By

4 Attorneys Listed

Warren J. Thomas

Email: wthomas@mcciplaw.com

Robert J. Leonard

Email: rleonard@mcciplaw.com

John W. Harbin

Email: jharbin@mcciplaw.com

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Plaintiff

Allergan Industrie SAS Operating Company

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Allergan USA, Inc. Operating Company

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 6 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (6 found):
PTAB: 6
USPTO PTAB Trial 2020-06-02
IPR2020-00902

Prollenium US Inc. et al. v. Allergan Industrie, SAS et al.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2020-06-02
IPR2020-00901

Prollenium US Inc. et al. v. Allergan Industrie, SAS et al.

U.S. Continuation Sibling (10485896)
Status: Terminated-Settled
USPTO PTAB Trial 2019-09-03
IPR2019-01509

Prollenium US, Inc. v. Allergan Industrie, SAS

U.S. Continuation Sibling (9358322)
Status: Terminated-Settled
USPTO PTAB Trial 2019-09-03
IPR2019-01505

Prollenium US, Inc. v. Allergan Industrie, SAS

U.S. Continuation Sibling (8450475)
Status: Terminated-Settled
USPTO PTAB Trial 2017-08-24
IPR2017-02002

TEOXANE S.A. v. Allergan, plc et al.

U.S. Continuation Sibling (8450475)
Status: Institution Denied
USPTO PTAB Trial 2014-08-29
IPR2014-01417

Galderma S.A. et al. v. Allergan Industrie, SAS et al.

U.S. Continuation Sibling (8450475)
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US10391202
Hyaluronic acid-based gels including lidocaine
Filed: 2018-11-09
Issued: 2019-08-27
Active (12.0 yrs remaining)
Expires: 2038-11-09
US10485896
Hyaluronic acid-based gels including lidocaine
Filed: 2018-11-09
Issued: 2019-11-26
Active (12.0 yrs remaining)
Expires: 2038-11-09

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

27

Dispositive

18

Granted

2

Denied

0

Pending / Review

14

Motions by Category

Procedural / Extension Motion 5 Motion to Dismiss (FRCP 12(b)(6)) 3 Motion to Stay Pending IPR / Reexam 15 Motion to Stay 4

Key Dispositive Motions & Rulings

Motion to Stay Pending IPR / Reexam Pending / Under Review
REPLY BRIEF re 30 MOTION to Stay pending outcome of IPR proceedings (renewed) filed by Prollenium Medical Technologies Inc., Prollenium US Inc.. (Mayo, Andrew) ...
Entry #33 • 2020-06-29 Document →
Motion to Stay Pending IPR / Reexam Pending
ANSWERING BRIEF in Opposition re 30 MOTION to Stay pending outcome of IPR proceedings (renewed) filed by Allergan Industrie SAS, Allergan USA, Inc..Reply Brief ...
Entry #32 • 2020-06-22 Document →
Motion to Stay Pending IPR / Reexam Pending / Under Review
ANSWERING BRIEF in Opposition re 30 MOTION to Stay pending outcome of IPR proceedings (renewed) filed by Allergan Industrie SAS, Allergan USA, Inc..Reply Brief ...
Entry #32 • 2020-06-22 Document →
Motion to Stay Pending IPR / Reexam Pending
MOTION to Stay pending outcome of IPR proceedings (renewed) - filed by Prollenium Medical Technologies Inc., Prollenium US Inc.. (Attachments: # 1 Exhibit A-B, ...
Entry #30 • 2020-06-08 Document →
Motion to Stay Pending IPR / Reexam Pending
MOTION to Stay pending outcome of IPR proceedings (renewed) - filed by Prollenium Medical Technologies Inc., Prollenium US Inc.. (Attachments: # 1 Exhibit A-B, ...
Entry #30 • 2020-06-08 Document →
Motion to Stay Pending IPR / Reexam Granted
MOTION to Stay pending outcome of IPR proceedings (renewed) - filed by Prollenium Medical Technologies Inc., Prollenium US Inc.. (Attachments: # 1 Exhibit A-B, ...
Entry #30 • 2020-06-08 Document →

Docket Entries

(80 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Prollenium Medical Technologies Inc. and Prollenium US Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2833450) - filed by Allergan USA, Inc., Allergan Industrie SAS. (Attachments: # 1 Exhibits A-B, # 2 Civil Cover Sheet)(amf) (Entered: 01/23/2020)

Entry #1 • 2020-01-23
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Prollenium Medical Technologies Inc. and Prollenium US Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2833450) - filed by Allergan USA, Inc., Allergan Industrie SAS. (Attachments: # 1 Exhibits A-B, # 2 Civil Cover Sheet)(amf) (Entered: 01/23/2020)

Entry #1 • 2020-01-23
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Prollenium Medical Technologies Inc. and Prollenium US Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2833450) - filed by Allergan USA, Inc., Allergan Industrie SAS. (Attachments: # 1 Exhibits A-B, # 2 Civil Cover Sheet)(amf) (Entered: 01/23/2020)

Entry #1 • 2020-01-23
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf) (Entered: 01/23/2020)

Entry #2 • 2020-01-23
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,391,202 B2 and 10,485,896 B2. (amf) (Entered: 01/23/2020)

Entry #3 • 2020-01-23
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc